Biotech Acquisition Company (BIOT)
NASDAQ: BIOT · IEX Real-Time Price · USD
9.90
0.00 (0.00%)
Jul 1, 2022 4:30 PM EDT - Market closed
Company Description
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses.
The company was incorporated in 2020 and is based in New York, New York.
Biotech Acquisition Company
| Country | United States |
| Founded | 2020 |
| IPO Date | Jan 26, 2021 |
| Industry | Blank Check / SPAC |
| Employees | 4 |
Contact Details
Address:
545 West 25th Street New York, NY 10001 United States | |
| Phone | 212 227 1905 |
Stock Details
| Ticker Symbol | BIOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | US Dollars |
| IPO Price | $10.00 |
| CIK Code | 1825413 |
| ISIN Number | KYG1125A1085 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michael Shleifer Ph.D. | Chairman and Chief Executive Officer |
| Thomas Fratacci | Chief Financial Officer and Treasurer |
| Ivan Jarry | Chief Operating Officer |
| Albert F. Hummel M.B.A. | Chief Investment Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 17, 2022 | RW | Registration Withdrawal Request |
| Jun 17, 2022 | 8-K | Current report |
| Jun 13, 2022 | 8-K | Current report |
| Jun 2, 2022 | 425 | Prospectuses and communications, business combinations |
| Jun 2, 2022 | 8-K | Current report |
| May 31, 2022 | 425 | Prospectuses and communications, business combinations |
| May 31, 2022 | 8-K | Current report |
| May 24, 2022 | 425 | Prospectuses and communications, business combinations |
| May 23, 2022 | 424B3 | Prospectus [Rule 424(b)(3)] |
| May 23, 2022 | 425 | Prospectuses and communications, business combinations |